Key facts
- This page summarizes Augustine Lawlor's Form 4 filing for LEAP THERAPEUTICS, INC. (LPTX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Oct 2024, 17:24.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of October 2, 2024.